Clinical Trials Logo

Filter by:
NCT ID: NCT03529851 Completed - Clinical trials for Lung Cancer Stage IV

Feasibility of a Web-based Patient Reported Outcome Symptom Monitoring Application in Danish Lung Cancer Patients

Start date: May 1, 2018
Phase: N/A
Study type: Interventional

The trial is a pilot study prior to a following phase III trial and is designed to test the feasibility, acceptability and technical usability of supplementary web-based follow-up in lung cancer via a patient-reported outcome application.

NCT ID: NCT03529357 Completed - Health Behavior Clinical Trials

Biological Age in Worksite Health Promotion

BA1
Start date: June 2007
Phase:
Study type: Observational

This cohort study investigates how implementation of Biological Age technology in worksite health promotion, affects health behavior in the general Danish working population.

NCT ID: NCT03528746 Completed - Patellar Tendinitis Clinical Trials

The Acute Effect of Isometric Versus Isotonic Resistance Exercise in Patients With Patellar Tendinopathy

Start date: July 12, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to compare the acute effects of two different types of resistance exercise (isometric versus isotonic) on exercise induced hypoalgesia during an aggravating activity, in participants with patellar tendinopathy.

NCT ID: NCT03528551 Completed - Clinical trials for Congenital Bleeding Disorder

A Research Study Looking at How a Factor VIII Medicine Called Turoctocog Alfa Pegol (N8-GP) Works in People With Haemophilia A

pathfinder8
Start date: April 30, 2018
Phase: Phase 3
Study type: Interventional

This study will look at how a known study medicine N8-GP works in previously N8-GP treated people with haemophilia A. The aim is to look at how N8-GP works during regular use. Participants will get N8-GP. N8-GP has been tested in more than 200 people with haemophilia A for several years. Participants will get an injection of N8-GP into a blood vessel, one, two or three times weekly. Participants will get more doses if they bleed or if they will need a surgery. The study will last for about 2 years. Participants will have at least 9 visits with the study doctor. If participants agree to be in this study, they will get their first injection (in this study) at the first visit. Participants will also get an injection at visit 3, 5 and 7. Participants will be trained to give all other injections themselves. Participants must not use any clotting factors other than N8-GP or any anticoagulants (blood thinners) during the study.

NCT ID: NCT03526471 Completed - Atrial Fibrillation Clinical Trials

Omega™ Left Atrial Appendage (LAA) Occluder in Patients With Non-Valvular Atrial Fibrillation

Start date: June 1, 2019
Phase: N/A
Study type: Interventional

Atrial fibrillation is associated with increased risk of stroke mostly because of clot formation in the left atrial appendage, a small alcove in the left atrium heart chamber. Plugging this appendage with an implantable plug type device, which is placed via a catheter painlessly in the femoral vein, has been proven to be a reliable alternative to the standard anti-clotting medication in a number of recent international trials. The Omega device is a new design of such a plug, made from biocompatible and compressible nitinol and fabric. Up to 195 patients will be enrolled in Europe, assuming that enrolment will stop once the Omega™ device has been successfully implanted in 150 evaluable patients. The primary performance endpoint of the study is LAA closure (defined as complete seal or efficient seal with a peri-device leak ≤ 5 mm) at 60 days (+/- 15 days) visit documented by transoesophageal echocardiogram (TEE/TOE) with colour flow Doppler.

NCT ID: NCT03526445 Completed - Diabetes Mellitus Clinical Trials

Hepatic Metabolic Changes in Response to Glucagon Infusion

Start date: May 1, 2018
Phase: N/A
Study type: Interventional

The objective of the study is to investigate how exogenously administered glucagon affects hepatic lipid, glucose and protein metabolism as well as appetite, food intake and resting energy expenditure.

NCT ID: NCT03526289 Completed - Clinical trials for Type 2 Diabetes Mellitus

GIP/GLP-1 Co-Activity in Subjects With Overweight and Type 2 Diabetes: Lowering of Food Intake

GASOLIN II
Start date: November 8, 2017
Phase: N/A
Study type: Interventional

The primary aim of the study is to evaluate how GIP receptor activation influence food intake and mechanisms regulating food intake in obese individuals with type 2 diabetes that are in steady treatment with metformin and a GLP-1 receptor agonist.

NCT ID: NCT03525314 Completed - Clinical trials for Achilles Tendon Rupture

Development of Achilles Tendon Elongation and Its Effect on Physical Function the First Year After Rupture

Start date: June 6, 2018
Phase:
Study type: Observational

The objective of this study is to examine how elongation of the Achilles tendon develops during the first year after rupture among patients with an Achilles tendon rupture, and how it affects physical function. The aim is to define a cutoff of acceptable elongation dividing the patients who obtain normal physical function (Limb Symmetry Index > 90%) from those who do not. Patients treated both operatively and non-operatively will be included.

NCT ID: NCT03524781 Completed - Clinical trials for Gastroesophageal Reflux

Treatment of Newly Diagnosed Gastroesophageal Reflux Disease in a National Population-based Cohort

Start date: May 2, 2018
Phase:
Study type: Observational [Patient Registry]

This study evaluates the treatment of newly diagnosed gastro-esophageal reflux disease in a Danish national cohort, comparing medical and surgical treatment.

NCT ID: NCT03524040 Completed - Acne Vulgaris Clinical Trials

Imaging of Pilosebaceous Units and Acne Lesions by RCM and OCT Confocal Microscopy and Optical Coherence Tomography

Start date: December 2016
Phase: N/A
Study type: Interventional

The purpose of the study was to investigate if reflectance confocal microscopy (RCM) and optical coherence tomography (OCT) could be used in combination to investigate the morphology of pilosebaceous units and acne lesions in healthy subjects and in acne patients.Furthermore, to investigate contrast effects, biodistribution and selective photothermolysis provided by gold microparticles and diode laser pulses, using RCM, OCT and histology.